These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9685233)

  • 21. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
    Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test.
    Block C; Robenshtok E; Simhon A; Shapiro M
    J Hosp Infect; 2000 Oct; 46(2):147-52. PubMed ID: 11049709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances.
    Mahboobi S; Eichhorn E; Popp A; Sellmer A; Elz S; Möllmann U
    Eur J Med Chem; 2006 Feb; 41(2):176-91. PubMed ID: 16375991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
    Emami S; Foroumadi A; Faramarzi MA; Samadi N
    Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
    Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
    J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.
    Tanino T; Al-Dabbagh B; Mengin-Lecreulx D; Bouhss A; Oyama H; Ichikawa S; Matsuda A
    J Med Chem; 2011 Dec; 54(24):8421-39. PubMed ID: 22085339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete.
    McArthur KA; Mitchell SS; Tsueng G; Rheingold A; White DJ; Grodberg J; Lam KS; Potts BC
    J Nat Prod; 2008 Oct; 71(10):1732-7. PubMed ID: 18842058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity.
    Tanitame A; Oyamada Y; Ofuji K; Suzuki K; Ito H; Kawasaki M; Wachi M; Yamagishi J
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2863-6. PubMed ID: 15125948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activities of naphthazarins from Arnebia euchroma.
    Shen CC; Syu WJ; Li SY; Lin CH; Lee GH; Sun CM
    J Nat Prod; 2002 Dec; 65(12):1857-62. PubMed ID: 12502328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds.
    Yamamoto Y; Kurazono M
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1626-8. PubMed ID: 17254785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
    Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
    J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel antibacterial iridoid and triterpene from Caiophora coronata.
    Khera S; Woldemichael GM; Singh MP; Suarez E; Timmermann BN
    J Nat Prod; 2003 Dec; 66(12):1628-31. PubMed ID: 14695811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antibacterial activity of a series of alpha-substituted acetylpiperazinyl oxazolidinones.
    Wang XJ; Du GJ; Zhao SQ; Yan M; Gu LQ
    Chem Biol Drug Des; 2009 Sep; 74(3):276-81. PubMed ID: 19703029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial effect and toxicity of synthesized salicylanilide derivatives.
    Ghazi IM; Mohamed ZA; Ismail SA; Kamal A
    Zentralbl Mikrobiol; 1986; 141(3):225-32. PubMed ID: 3094282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of the Enterococcus faecium BM4147 vancomycin resistance gene cluster by the VanS-VanR two-component regulatory system in Escherichia coli K-12.
    Haldimann A; Fisher SL; Daniels LL; Walsh CT; Wanner BL
    J Bacteriol; 1997 Sep; 179(18):5903-13. PubMed ID: 9294451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel antibacterial compounds specifically targeting the essential WalR response regulator.
    Gotoh Y; Doi A; Furuta E; Dubrac S; Ishizaki Y; Okada M; Igarashi M; Misawa N; Yoshikawa H; Okajima T; Msadek T; Utsumi R
    J Antibiot (Tokyo); 2010 Mar; 63(3):127-34. PubMed ID: 20111065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus.
    Niu S; Liu D; Hu X; Proksch P; Shao Z; Lin W
    J Nat Prod; 2014 Apr; 77(4):1021-30. PubMed ID: 24571273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.